European Hospitals Invest in Advanced Wound Care Products
By HospiMedica International staff writers Posted on 01 Jun 2014 |
The rising incidence of lifestyle diseases and an expanding, aging population are driving the sales volumes of wound care and closure products across Europe. These are the latest findings of Frost & Sullivan (Frost; London, United Kingdom), an international market research firm.
Hospitals in both Western and Eastern Europe are increasingly showing a preference for advanced wound care products that accelerate healing, as they realize that prolonged hospital stays and bed occupancy are a bigger cost burden than investment in these solutions. Patients as well are finding that advanced wound care products are easier to use and more comfortable than traditional ones, giving a boost to the adoption rates. The increase in the volume of open surgical procedures is also fuelling demand for wound closure products.
As a result, doctors across Western and Eastern Europe are particularly adopting new wound closure technologies that support scar-free surgery. However, the lack of reimbursement for some of these advanced wound care and closure products is lowering market potential. The market is further complicated by the proliferation of products from Asian markets and other regions. Moreover, the inability of hospitals to invest in costly technologies such as negative pressure wound therapy (NPWT) is forcing market participants to reassess their pricing strategies.
“Wound care product manufacturers have already started making NPWT and other active therapies more affordable by introducing rental models, portable solutions, and other cost-effective alternatives,” said Frost & Sullivan healthcare research analyst Parthasarathy Raghava. “They should continue finding ways to ensure that high-technology wound care solutions fit into current healthcare budgets.”
According to the Frost report, innovative pricing strategies and product differentiation will be vital to increase profits, and wound closure product manufacturers will do well to launch products that have unique features and can deal with multiple types of wounds to stand out from the competition. Frost & Sullivan have found that the Western and Eastern European wound care and wound closure market earned revenues of USD 4.41 billion in 2013, and estimates that this could reach USD 6.41 billion in 2019.
Related Links:
Frost & Sullivan
Hospitals in both Western and Eastern Europe are increasingly showing a preference for advanced wound care products that accelerate healing, as they realize that prolonged hospital stays and bed occupancy are a bigger cost burden than investment in these solutions. Patients as well are finding that advanced wound care products are easier to use and more comfortable than traditional ones, giving a boost to the adoption rates. The increase in the volume of open surgical procedures is also fuelling demand for wound closure products.
As a result, doctors across Western and Eastern Europe are particularly adopting new wound closure technologies that support scar-free surgery. However, the lack of reimbursement for some of these advanced wound care and closure products is lowering market potential. The market is further complicated by the proliferation of products from Asian markets and other regions. Moreover, the inability of hospitals to invest in costly technologies such as negative pressure wound therapy (NPWT) is forcing market participants to reassess their pricing strategies.
“Wound care product manufacturers have already started making NPWT and other active therapies more affordable by introducing rental models, portable solutions, and other cost-effective alternatives,” said Frost & Sullivan healthcare research analyst Parthasarathy Raghava. “They should continue finding ways to ensure that high-technology wound care solutions fit into current healthcare budgets.”
According to the Frost report, innovative pricing strategies and product differentiation will be vital to increase profits, and wound closure product manufacturers will do well to launch products that have unique features and can deal with multiple types of wounds to stand out from the competition. Frost & Sullivan have found that the Western and Eastern European wound care and wound closure market earned revenues of USD 4.41 billion in 2013, and estimates that this could reach USD 6.41 billion in 2019.
Related Links:
Frost & Sullivan
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures